Literature DB >> 29781043

Comparison of Four Days Versus Seven Days Duration of Antibiotic Therapy for Neonatal Pneumonia: A Randomized Controlled Trial.

N B Mathur1, A Murugesan2.   

Abstract

OBJECTIVE: To compare the effect of 4 day course (study group) with 7 day course (control group) of antibiotic treatment in neonatal pneumonia, on treatment success rate.
METHODS: This randomized controlled trial was conducted in a tertiary teaching hospital. Seventy, term and near-term neonates with pneumonia who had clinical remission by 48 h of antibiotic therapy were included. The neonates were randomized to receive a total of 4 d of antibiotics (Group 1) or 7 d of antibiotics (Group 2). The outcome measure was treatment failure in each group within 3 d of discharge.
RESULTS: The treatment success rate of both the groups was 100%. There was a significant reduction in the duration of hospital stay (p < 0.001), antibiotic usage (p < 0.001), and cost (p < 0.001) in the 4 d group. On follow up till 28 d of enrollment, no infective morbidity was found in either group.
CONCLUSIONS: For term and near-term neonates who become clinically asymptomatic within 48 h of antibiotic therapy, 4 d of antibiotic therapy is as effective and safe as 7 d of antibiotic therapy, with significant reduction in hospital stay, antibiotic usage and cost.

Entities:  

Keywords:  Duration of antibiotics; Effectiveness; Neonatal pneumonia; Treatment failure

Mesh:

Substances:

Year:  2018        PMID: 29781043     DOI: 10.1007/s12098-018-2708-y

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  22 in total

1.  How to calculate sample size in randomized controlled trial?

Authors:  Baoliang Zhong
Journal:  J Thorac Dis       Date:  2009-12       Impact factor: 2.895

2.  Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial.

Authors:  Mirjam Christ-Crain; Daiana Stolz; Roland Bingisser; Christian Müller; David Miedinger; Peter R Huber; Werner Zimmerli; Stephan Harbarth; Michael Tamm; Beat Müller
Journal:  Am J Respir Crit Care Med       Date:  2006-04-07       Impact factor: 21.405

3.  Short course versus 7-day course of intravenous antibiotics for probable neonatal septicemia: a pilot, open-label, randomized controlled trial.

Authors:  Shiv Sajan Saini; Sourabh Dutta; Pallab Ray; Anil Narang
Journal:  Indian Pediatr       Date:  2010-08-01       Impact factor: 1.411

4.  Ten days vs. 14 days antibiotic therapy in culture-proven neonatal sepsis.

Authors:  Geeta Gathwala; Arvind Sindwani; Jagjit Singh; Ojasvini Choudhry; Uma Chaudhary
Journal:  J Trop Pediatr       Date:  2010-02-25       Impact factor: 1.165

5.  Randomized controlled trial of 7-Day vs. 14-Day antibiotics for neonatal sepsis.

Authors:  G Chowdhary; S Dutta; A Narang
Journal:  J Trop Pediatr       Date:  2006-10-09       Impact factor: 1.165

6.  Use of procalcitonin-guided decision-making to shorten antibiotic therapy in suspected neonatal early-onset sepsis: prospective randomized intervention trial.

Authors:  Martin Stocker; Matteo Fontana; Salhab El Helou; Karl Wegscheider; Thomas M Berger
Journal:  Neonatology       Date:  2009-09-24       Impact factor: 4.035

7.  Pneumonia in neonates: can it be managed in the community?

Authors:  A T Bang; R A Bang; V P Morankar; P G Sontakke; J M Solanki
Journal:  Arch Dis Child       Date:  1993-05       Impact factor: 3.791

Review 8.  The role of C-reactive protein in the evaluation and management of infants with suspected sepsis.

Authors:  Joan M Hengst
Journal:  Adv Neonatal Care       Date:  2003-02       Impact factor: 1.968

9.  Respiratory distress in neonates with special reference to pneumonia.

Authors:  N B Mathur; K Garg; S Kumar
Journal:  Indian Pediatr       Date:  2002-06       Impact factor: 1.411

Review 10.  Update on procalcitonin measurements.

Authors:  Michael Meisner
Journal:  Ann Lab Med       Date:  2014-06-19       Impact factor: 3.464

View more
  2 in total

Review 1.  Can We Reduce the Duration of Antibiotic Therapy for Neonatal Pneumonia?

Authors:  B Vishnu Bhat; B Adhisivam
Journal:  Indian J Pediatr       Date:  2018-07-28       Impact factor: 1.967

2.  Assessment of mechanisms of infectious pneumonia based on expression of fibrinogen, procalcitonin, high-sensitivity C-reactive protein expression, T helper 17 cells, regulatory T cells interleukin-10, and interleukin-17.

Authors:  Dao-Ming Zu; Lei Zhang
Journal:  Transl Pediatr       Date:  2022-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.